These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2536140)

  • 21. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
    Letvin NL; Miller MD; Shen L; Chen ZW; Yasutomi Y
    Semin Immunol; 1993 Jun; 5(3):215-23. PubMed ID: 8394161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.
    Harouse JM; Tan RC; Gettie A; Dailey P; Marx PA; Luciw PA; Cheng-Mayer C
    Virology; 1998 Aug; 248(1):95-107. PubMed ID: 9705259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
    Luciw PA; Mandell CP; Himathongkham S; Li J; Low TA; Schmidt KA; Shaw KE; Cheng-Mayer C
    Virology; 1999 Oct; 263(1):112-27. PubMed ID: 10544087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of uninfected immature hematopoietic cells from bone marrow of simian immunodeficiency virus infected rhesus monkeys.
    van Wely M; Slachmuylders JF; Visser TP; Dubbes RH; Niphuis H; Heeney JL; Wagemaker G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1279-80. PubMed ID: 7680153
    [No Abstract]   [Full Text] [Related]  

  • 25. Increase in plasmacytoid and myeloid dendritic cells by progenipoietin-1, a chimeric Flt-3 and G-CSF receptor agonist, in SIV-Infected rhesus macaques.
    Koopman G; Niphuis H; Haaksma AG; Farese AM; Casey DB; Kahn LE; Mann D; MacVittie TJ; Woulfe SL; Heeney JL
    Hum Immunol; 2004 Apr; 65(4):303-16. PubMed ID: 15120185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys.
    Watanabe N; Sypek JP; Mittler S; Reimann KA; Flores-Villanueva P; Voss G; Lord CI; Letvin NL
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):393-9. PubMed ID: 9546798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication.
    Reimann KA; Burkly LC; Burrus B; Waite BC; Lord CI; Letvin NL
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):199-207. PubMed ID: 8471310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment.
    Janot-Sardet C; Assouline B; Cheynier R; Morre M; Beq S
    J Immunol Methods; 2010 Feb; 353(1-2):115-23. PubMed ID: 20035760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary neopterin concentrations in rhesus monkeys after infection with simian immunodeficiency virus (SIVmac 251).
    Fendrich C; Lüke W; Stahl-Hennig C; Herchenröder O; Fuchs D; Wachter H; Hunsmann G
    AIDS; 1989 May; 3(5):305-7. PubMed ID: 2548536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloma-like cast nephropathy caused by human recombinant soluble CD4 (sCD4) in monkeys.
    Bugelski PJ; Solleveld HA; Fong KL; Klinkner AM; Hart TK; Morgan DG
    Am J Pathol; 1992 Mar; 140(3):531-7. PubMed ID: 1546739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies.
    Daniel MD; Desrosiers RC
    AIDS; 1989; 3 Suppl 1():S131-3. PubMed ID: 2558686
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunologic developments in AIDS--1987.
    Jacobs JL
    Year Immunol; 1989; 4():276-85. PubMed ID: 2538974
    [No Abstract]   [Full Text] [Related]  

  • 34. Simian immunodeficiency viruses.
    Desrosiers RC
    Annu Rev Microbiol; 1988; 42():607-25. PubMed ID: 2849374
    [No Abstract]   [Full Text] [Related]  

  • 35. Chimpanzees immunized with recombinant soluble CD4 develop anti-self CD4 antibody responses with anti-human immunodeficiency virus activity.
    Watanabe M; Boyson JE; Lord CI; Letvin NL
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5103-7. PubMed ID: 1594618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus enteritis in SIV-infected rhesus monkeys.
    Baskin GB; Soike KF
    J Infect Dis; 1989 Nov; 160(5):905-7. PubMed ID: 2553828
    [No Abstract]   [Full Text] [Related]  

  • 37. The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain.
    Funke I; Hahn A; Rieber EP; Weiss E; Riethmüller G
    J Exp Med; 1987 Apr; 165(4):1230-5. PubMed ID: 3104529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion of HIV-1 and SIVmac with liposomes and modulation of HIV-1 infectivity.
    Düzgüneş N; Larsen CE; Konopka K; Alford DR; Young LJ; McGraw TP; Davis BR; Nir S; Jennings M
    Adv Exp Med Biol; 1991; 300():167-89; discussion 190-2. PubMed ID: 1664176
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of recombinant soluble CD4 on the in vitro growth of hematopoietic progenitor cells from AIDS patients.
    Molina JM; Sakaguchi M; Groopman JE
    Blood; 1990 Mar; 75(6):1379-80. PubMed ID: 2310836
    [No Abstract]   [Full Text] [Related]  

  • 40. Soluble recombinant CD4--a potential therapeutic agent for HIV infection.
    Rosenberg M; Bugelski PJ; Fong KL; Drutz DJ; Sweet RW; Webb DD
    Biotherapy; 1990; 2(2):107-18. PubMed ID: 2205260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.